AstraZeneca said in a statement today that it has agreed to buy U. S. firm Pearl Therapeutics for up to $1.15 billion. Anglo-Swedish pharmaceuticals group AstraZeneca has entered an agreement to take over Pearl Therapeutics, which is a privately held company based in Redwood City, California.
As per reports, Omthera Pharmaceuticals will be acquired by AstraZeneca for $443 million. The merged company will establish itself in the field of cardiovascular drugs. The move is a second purchase in the cardiovascular field by AstraZeneca.
A study has come with facts that European forests are now coming close to saturation point. The CO2 absorption capability of continent's trees has been declining since 2005.
The research was published in Nature Climate Change. The...
A rail tunnel's trial run has been successfully accomplished by Turkey. The tunnel connects the...
During the course of her address at Intel's Datacenter Day on Monday, Diane Bryant - general...
It has been revealed that Statoil, Norway's state-controlled oil company, is going to reduce its stakes in different oilfields.
The company had a 75% stake in Gudrun oil fields and 70% in Gullfaks oil field in Norwegian waters. But now, it...
On Saturday, Europe failed to agree on how to share the cost of bank collapse on Saturday....
Retailer Best Buy has recently launched a pre-order system for Google's new updated Nexus 7...
A recent report has uncovered that the second-quarter core earnings of Telecom Austria (TELA. VI) have plunged by some 10%. The fall realized has come out to be a bit sharper than expected.
It is after more spending on subsidizing...
Not only its profusion of old-world charm, but the birth...
On Sunday, Mohamed ElBaradei, Egyptian Nobel laureate,...
Recently, a report about increasing use of Smarthphone...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).
Subscribe
